Cargando…
单中心394例广泛期小细胞肺癌的一线化疗及生存分析
BACKGROUND AND OBJECTIVE: Small cell lung cancer (SCLC) is the most malignant neuroendocrine tumor but highly sensitive to chemotherapy and radiotherapy. At present, the standard first-line chemotherapy regimen of extensive-stage SCLC is platinum combined etoposide regimen. However, most patients wh...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000203/ https://www.ncbi.nlm.nih.gov/pubmed/24398308 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.01.02 |